EVAg

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence of the NS2A region from Zika virus and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 24x4 rxns) for real time RT-PCR of Zika virus (Taqman) SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase. For RUO (research use only).

RNA extracted from infected cell culture supernatant of Zika virus strain MRS_OPY_Martinique_PaRi_2015. Virus Provenance Martinique 2015,

A specific RT-PCR was performed on KJ776791. The product was cloned into a vector, sequenced and in vitro transcribed. In vitro transcript: Vector Sequence: Position 1-36, 727-816 Insert Sequence: Position 37-726

A specific genome region was amplified by PCR, cloned into a vector and in vitro transcribed. In vitro transcript: Vector Sequence: 1-36, 632-721 Insert Sequence: 37-631

A specific RT-PCR was performed on KJ776791. The product was cloned into a vector, sequenced an in vitro transcribed. In vitro transcript: Vector Sequence: 1-36, 638-727 Insert Sequence: 37-637

A specific RT-PCR was performed on KJ776791. The product was cloned into a vector, sequenced an in vitro transcribed. In vitro transcript: Vector Sequence: 1-36, 674-763 Insert Sequence: 37-673

A specific RT-PCR was performed on KJ776791. The product was cloned into a vector, sequenced an in vitro transcribed. In vitro transcript: Vector Sequence: 1-36, 634-723 Insert Sequence: 37-633

In vitro transcribed RNA containing priming sites for different zika virus real time PCRs.

In vitro transcribed RNA that contains priming sites for different Zika virus rt-PCRs, encapsulated within a protective protein coat.